166 related articles for article (PubMed ID: 35869257)
1. NUPR1 protects against hyperPARylation-dependent cell death.
Santofimia-Castaño P; Huang C; Liu X; Xia Y; Audebert S; Camoin L; Peng L; Lomberk G; Urrutia R; Soubeyran P; Neira JL; Iovanna J
Commun Biol; 2022 Jul; 5(1):732. PubMed ID: 35869257
[TBL] [Abstract][Full Text] [Related]
2. NUPR1 inhibitor ZZW-115 induces ferroptosis in a mitochondria-dependent manner.
Huang C; Santofimia-Castaño P; Liu X; Xia Y; Peng L; Gotorbe C; Neira JL; Tang D; Pouyssegur J; Iovanna J
Cell Death Discov; 2021 Oct; 7(1):269. PubMed ID: 34599149
[TBL] [Abstract][Full Text] [Related]
3. Targeting NUPR1-dependent stress granules formation to induce synthetic lethality in Kras
Santofimia-Castaño P; Fraunhoffer N; Liu X; Bessone IF; di Magliano MP; Audebert S; Camoin L; Estaras M; Brenière M; Modesti M; Lomberk G; Urrutia R; Soubeyran P; Neira JL; Iovanna J
EMBO Mol Med; 2024 Mar; 16(3):475-505. PubMed ID: 38360999
[TBL] [Abstract][Full Text] [Related]
4. Targeting NUPR1 with the small compound ZZW-115 is an efficient strategy to treat hepatocellular carcinoma.
Lan W; Santofimia-Castaño P; Xia Y; Zhou Z; Huang C; Fraunhoffer N; Barea D; Cervello M; Giannitrapani L; Montalto G; Peng L; Iovanna J
Cancer Lett; 2020 Aug; 486():8-17. PubMed ID: 32446862
[TBL] [Abstract][Full Text] [Related]
5. ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.
Lan W; Santofimia-Castaño P; Swayden M; Xia Y; Zhou Z; Audebert S; Camoin L; Huang C; Peng L; Jiménez-Alesanco A; Velázquez-Campoy A; Abián O; Lomberk G; Urrutia R; Rizzuti B; Geli V; Soubeyran P; Neira JL; Iovanna J
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32780723
[TBL] [Abstract][Full Text] [Related]
6. Effects of the PARP Inhibitor Olaparib on the Response of Human Peripheral Blood Leukocytes to Bacterial Challenge or Oxidative Stress.
Santos SS; Brunialti MKC; Rodrigues LOCP; Liberatore AMA; Koh IHJ; Martins V; Soriano FG; Szabo C; Salomão R
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740913
[TBL] [Abstract][Full Text] [Related]
7. LPS protects macrophages from AIF-independent parthanatos by downregulation of PARP1 expression, induction of SOD2 expression, and a metabolic shift to aerobic glycolysis.
Regdon Z; Robaszkiewicz A; Kovács K; Rygielska Ż; Hegedűs C; Bodoor K; Szabó É; Virág L
Free Radic Biol Med; 2019 Feb; 131():184-196. PubMed ID: 30502458
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Stress-Induced Protein NUPR1 to Treat Pancreatic Adenocarcinoma.
Santofimia-Castaño P; Xia Y; Peng L; Velázquez-Campoy A; Abián O; Lan W; Lomberk G; Urrutia R; Rizzuti B; Soubeyran P; Neira JL; Iovanna J
Cells; 2019 Nov; 8(11):. PubMed ID: 31744261
[TBL] [Abstract][Full Text] [Related]
9. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation.
Wani WY; Sunkaria A; Sharma DR; Kandimalla RJ; Kaushal A; Gerace E; Chiarugi A; Gill KD
Neuroscience; 2014 Jan; 258():1-15. PubMed ID: 24231740
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of NUPR1 promotes cell death by coupling ER-stress responses with necrosis.
Santofimia-Castaño P; Lan W; Bintz J; Gayet O; Carrier A; Lomberk G; Neira JL; González A; Urrutia R; Soubeyran P; Iovanna J
Sci Rep; 2018 Nov; 8(1):16999. PubMed ID: 30451898
[TBL] [Abstract][Full Text] [Related]
11. Design of Inhibitors of the Intrinsically Disordered Protein NUPR1: Balance between Drug Affinity and Target Function.
Rizzuti B; Lan W; Santofimia-Castaño P; Zhou Z; Velázquez-Campoy A; Abián O; Peng L; Neira JL; Xia Y; Iovanna JL
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680086
[TBL] [Abstract][Full Text] [Related]
12. AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration.
Jang KH; Do YJ; Son D; Son E; Choi JS; Kim E
Cell Death Dis; 2017 Jan; 8(1):e2526. PubMed ID: 28055012
[TBL] [Abstract][Full Text] [Related]
13. Effect of parthanatos on ropivacaine-induced damage in SH-SY5Y cells.
Zheng T; Zheng CY; Zheng XC; Zhao RG; Chen YQ
Clin Exp Pharmacol Physiol; 2017 May; 44(5):586-594. PubMed ID: 28079261
[TBL] [Abstract][Full Text] [Related]
14. CASK Mediates Oxidative Stress-Induced Microglial Apoptosis-Inducing Factor-Independent Parthanatos Cell Death via Promoting PARP-1 Hyperactivation and Mitochondrial Dysfunction.
Cheong KJH; Huang DY; Sekar P; Chen RJ; Cheng IH; Chan CM; Chen YS; Lin WW
Antioxidants (Basel); 2024 Mar; 13(3):. PubMed ID: 38539876
[TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin induces the PARP1-mediated parthanatos in oral squamous cell carcinoma by increasing production of ROS.
Li D; Kou Y; Gao Y; Liu S; Yang P; Hasegawa T; Su R; Guo J; Li M
Aging (Albany NY); 2021 Jan; 13(3):4242-4257. PubMed ID: 33495407
[TBL] [Abstract][Full Text] [Related]
16. JNK Activation Contributes to Oxidative Stress-Induced Parthanatos in Glioma Cells via Increase of Intracellular ROS Production.
Zheng L; Wang C; Luo T; Lu B; Ma H; Zhou Z; Zhu D; Chi G; Ge P; Luo Y
Mol Neurobiol; 2017 Jul; 54(5):3492-3505. PubMed ID: 27181592
[TBL] [Abstract][Full Text] [Related]
17. Activation of cell death mediated by apoptosis-inducing factor due to the absence of poly(ADP-ribose) glycohydrolase.
Zhou Y; Feng X; Koh DW
Biochemistry; 2011 Apr; 50(14):2850-9. PubMed ID: 21366272
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agent.
Cloux AJ; Aubry D; Heulot M; Widmann C; ElMokh O; Piacente F; Cea M; Nencioni A; Bellotti A; Bouzourène K; Pellegrin M; Mazzolai L; Duchosal MA; Nahimana A
Oncotarget; 2019 Nov; 10(62):6723-6738. PubMed ID: 31803365
[TBL] [Abstract][Full Text] [Related]
19. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
20. NAD
Klimova N; Fearnow A; Long A; Kristian T
Exp Neurol; 2020 Mar; 325():113144. PubMed ID: 31837320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
